Top Story

Nivolumab shows promise for advanced hepatocellular carcinoma

May 29, 2015

CHICAGO — Nivolumab appeared safe and effective for the treatment of patients with advanced hepatocellular carcinoma, according to interim study results presented at the ASCO Annual Meeting.

The responses observed with nivolumab (Opdivo, Bristol-Myers Squibb) — a programmed cell death-1 (PD-1) antibody — also appeared durable, results showed.

Meeting News CoveragePerspective

Mismatch repair deficiency predicts response to pembrolizumab in several cancer types

May 29, 2015
CHICAGO — Mismatch repair deficiency may be the first genomic marker to predict how patients with cancer will respond to immune checkpoint blockade with the…
In the Journals

CDC: Cancer screening rates remain below Healthy People 2020 targets

May 29, 2015
 The number of adults in the U.S. who underwent the recommended screening tests for breast, colorectal and cervical cancers in 2013 fell below the targets set by…
In the Journals

Next-generation sequencing costeffective for evaluation of inherited colorectal cancer, polyposis syndromes

May 28, 2015
The use of next-generation sequencing panels that included highly penetrant genes associated with colorectal cancer and polyposis syndromes in addition to Lynch syndrome…
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Colonoscopy-preparation app considered easy to use, engaging

Colonoscopy-preparation app considered easy to use, engaging

October 25, 2013
SAN DIEGO —Sundeep Singh, MD, reports a smartphone-based application to help patients prepare themselves for a…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage

Nivolumab shows promise for advanced hepatocellular carcinoma

May 29, 2015
CHICAGO — Nivolumab appeared safe and effective for the treatment of patients with advanced hepatocellular carcinoma, according to interim…
Meeting News CoveragePerspective

Mismatch repair deficiency predicts response to pembrolizumab in several cancer types

May 29, 2015
CHICAGO — Mismatch repair deficiency may be the first genomic marker to predict how patients with cancer will respond to immune checkpoint…
In the Journals

CDC: Cancer screening rates remain below Healthy People 2020 targets

May 29, 2015
 The number of adults in the U.S. who underwent the recommended screening tests for breast, colorectal and cervical cancers in 2013 fell below…
In the Journals

Next-generation sequencing costeffective for evaluation of inherited colorectal cancer, polyposis syndromes

May 28, 2015
The use of next-generation sequencing panels that included highly penetrant genes associated with colorectal cancer and polyposis syndromes in…
In the Journals

Cancer diagnosis may encourage smoking cessation

May 27, 2015
The receipt of a cancer diagnosis was associated with sustained smoking cessation regardless of the cancer’s prognosis or relation to smoking…
Meeting News Coverage

Mutational load predicts progression in patients with Barrett's esophagus

May 26, 2015
Genetic mutations at several key loci predicted whether patients with Barrett’s esophagus who had no dysplasia or low-grade dysplasia at…

Enrollment open for phase 2 trial of Melphalan/HDS for HCC

May 25, 2015
Delcath Systems, Inc. announced the intrahepatic cholangiocarcinoma study cohort of its global phase 2 trial of Melphalan/HDS therapy for the…
Brain, cardiac death allografts did not increase HCC recurrence In the Journals

Brain, cardiac death allografts did not increase HCC recurrence

May 21, 2015
Donations after brain and cardiac death allografts did not increase a patient’s likelihood of developing hepatocellular carcinoma recurrence…
In the Journals

Gastrointestinal stromal tumors increase risk for additional malignancies

May 19, 2015
Patients with gastrointestinal stromal tumors faced an increased risk for developing additional cancers before and after their diagnosis, according…
Meeting News Coverage

Endoscopic resection of high risk colorectal carcinoma does not negatively affect patient outcomes

May 18, 2015
WASHINGTON — Patient outcomes are not negatively affected by the endoscopic resection of high-risk colorectal carcinomas followed by surgery…
More Headlines »
morganatic-roan
morganatic-roan